Cognitive impairment is a significant cause of disability for many people with Multiple Sclerosis (MS). To alleviate or slow the progression of cognitive impairment, pharmacological interventions are studied – but do they work? On this episode, Dr. Katherine Knox and Dr. Sarah Morrow share key findings from MSBEST’s systematic review on pharmacological interventions for cognitive impairment in MS. They discuss which interventions may help, which don’t work, and where more research is needed.